FAB-144 is an indazole-based synthetic cannabinoid that is presumed to be a potent agonist of the CB1 receptor and has been sold online as a designer drug.[1] It is the indazole analogue of XLR-11.

Sweden's public health agency suggested classifying FAB-144 as a hazardous substance on November 10, 2014.[2]

See also

References

  1. ^ "FAB-144". Cayman Chemical. Retrieved 23 July 2015.
  2. ^ "Cannabinoider föreslås bli klassade som hälsofarlig vara". Folkhälsomyndigheten. Retrieved 23 July 2015.


Allikas: https://en.wikipedia.org/wiki/FAB-144
No tags for this post.